The CXCR2 chemokine receptor: A new target for gastric cancer therapy

被引：0
作者：
Kang, Wenyan [1 ]
Wang, Chengkun [1 ]
Wang, Minhui [1 ]
Liu, Meiqi [1 ]
Hu, Wei
Liang, Xiaoqiu [1 ]
Zhang, Yang [1 ]
机构：
[1] Univ South China, Hengyang Med Sch, Canc Res Inst, Hunan Prov Key Lab Tumor Cellular & Mol Pathol, Hengyang, Hunan, Peoples R China
来源：
CYTOKINE | 2024年 / 181卷
关键词：
CXCR2; Gastric cancer; Inflammation; Pathway; Therapy; TUMOR-ASSOCIATED MACROPHAGES; IMMATURE MYELOID CELLS; BREAST-CANCER; MELANOMA GROWTH; IN-VITRO; PROMOTES METASTASIS; HUMAN INTERLEUKIN-8; SUPPRESSOR-CELLS; POOR-PROGNOSIS; STEM-CELLS;
D O I：
10.1016/j.cyto.2024.156675
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Gastric cancer (GC) is one of the most common malignant tumors in the world, and current treatments are still based on surgery and drug therapy. However, due to the complexity of immunosuppression and drug resistance, the treatment of gastric cancer still faces great challenges. Chemokine receptor 2 (CXCR2) is one of the most common therapeutic targets in targeted therapy. As a G protein-coupled receptor, CXCR2 and its ligands play important roles in tumorigenesis and progression. The abnormal expression of these genes in cancer plays a decisive role in the recruitment and activation of white blood cells, angiogenesis, and cancer cell proliferation, and CXCR2 is involved in various stages of tumor development. Therefore, interfering with the interaction between CXCR2 and its ligands is considered a possible target for the treatment of various tumors, including gastric cancer.
引用
收藏
页数：11
相关论文
共 136 条
  • [1] A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
    Acharyya, Swarnali
    Oskarsson, Thordur
    Vanharanta, Sakari
    Malladi, Srinivas
    Kim, Juliet
    Morris, Patrick G.
    Manova-Todorova, Katia
    Leversha, Margaret
    Hogg, Nancy
    Seshan, Venkatraman E.
    Norton, Larry
    Brogi, Edi
    Massague, Joan
    [J]. CELL, 2012, 150 (01) : 165 - 178
  • [2] The CXC chemokines growth-regulated oncogene (GRO) alpha, GRO beta, GRO gamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor
    Ahuja, SK
    Murphy, PM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) : 20545 - 20550
  • [3] Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5
    Ando, Yohei
    Ohuchida, Kenoki
    Otsubo, Yoshiki
    Kibe, Shin
    Takesue, Shin
    Abe, Toshiya
    Iwamoto, Chika
    Shindo, Koji
    Moriyama, Taiki
    Nakata, Kohei
    Miyasaka, Yoshihiro
    Ohtsuka, Takao
    Oda, Yoshinao
    Nakamura, Masafumi
    [J]. PLOS ONE, 2020, 15 (01):
  • [4] Autocrine CXCL8-dependent invasiveness triggers modulation of actin cytoskeletal network and cell dynamics
    Antonosante, Andrea
    Brandolini, Laura
    d'Angelo, Michele
    Benedetti, Elisabetta
    Castelli, Vanessa
    Del Maestro, Mattia
    Luzzi, Sabino
    Giordano, Antonio
    Cimini, Annamaria
    Allegretti, Marcello
    [J]. AGING-US, 2020, 12 (02): : 1928 - 1951
  • [5] CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial
    Armstrong, Andrew J.
    Geva, Ravit
    Chung, Hyun Cheol
    Lemech, Charlotte
    Miller Jr., Wilson H.
    Hansen, Aaron R.
    Lee, Jong-Seok
    Tsai, Frank
    Solomon, Benjamin J.
    Kim, Tae Min
    Rolfo, Christian
    Giranda, Vincent
    Ren, Yixin
    Liu, Fang
    Kandala, Bhargava
    Freshwater, Tomoko
    Wang, Judy S.
    [J]. INVESTIGATIONAL NEW DRUGS, 2024, 42 (01) : 145 - 159
  • [6] Mice That Express Human Interleukin-8 Have Increased Mobilization of Immature Myeloid Cells, Which Exacerbates Inflammation and Accelerates Colon Carcinogenesis
    Asfaha, Samuel
    Dubeykovskiy, Alexander N.
    Tomita, Hiroyuki
    Yang, Xiangdong
    Stokes, Sarah
    Shibata, Wataru
    Friedman, Richard A.
    Ariyama, Hiroshi
    Dubeykovskaya, Zinaida A.
    Muthupalani, Sureshkumar
    Ericksen, Russell
    Frucht, Harold
    Fox, James G.
    Wang, Timothy C.
    [J]. GASTROENTEROLOGY, 2013, 144 (01) : 155 - 166
  • [7] Blockade of CXCR2 signalling: A potential therapeutic target for preventing neutrophil-mediated inflammatory diseases
    Boppana, Nithin B.
    Devarajan, Asokan
    Gopal, Kaliappan
    Barathan, Muttiah
    Bakar, Sazaly A.
    Shankar, Esaki M.
    Ebrahim, Abdul S.
    Farooq, Shukkur M.
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 239 (05) : 509 - 518
  • [8] CHARACTERIZATION OF THE ROLE OF MELANOMA GROWTH STIMULATORY ACTIVITY (MGSA) IN THE GROWTH OF NORMAL MELANOCYTES, NEVOCYTES, AND MALIGNANT MELANOCYTES
    BORDONI, R
    FINE, R
    MURRAY, D
    RICHMOND, A
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1990, 44 (04) : 207 - 219
  • [9] The Promise of Targeting Macrophages in Cancer Therapy
    Brown, J. Martin
    Recht, Lawrence
    Strober, Samuel
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (13) : 3241 - 3250
  • [10] KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway
    Burger, M
    Hartmann, T
    Burger, JA
    Schraufstatter, I
    [J]. ONCOGENE, 2005, 24 (12) : 2067 - 2075
12345678910